Ernexa Therapeutics posts updated investor presentation on February 26, 2026

Ernexa Therapeutics Inc.

Updated presentation replaces the December 11, 2025 version; available on company website.
Presentation furnished under Item 7.01 Regulation FD; no financial statements or material agreements attached.
Specific content of the update is not disclosed in the filing; investors should review the presentation directly.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.